Skip to main content
    C

    CDT Equity Inc. (CDT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.38
    -0.02 (-5.84%)

    Market Cap: $407,550

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CDT Equity Inc. (CDT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to CDT Equity are Karyopharm Therapeutics (KPTI), CERo Therapeutics Holdings, Inc. Common Stock (CERO) and Onconetix (ONCO). By market cap, CDT Equity ranks 11th of the 13 companies on this page; Onconetix (ONCO) is the largest at $2.15M.

    Peer Comparison

    CDT's revenue growth of 0.0% is above the peer median of -6.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    CDT Equity (CDT)$407550N/AN/A0.0%N/A0.0%0.00%
    Karyopharm Therapeutics Inc (KPTI)$394660N/AN/A-153.3%64.5%-11.9%0.00%
    CERo Therapeutics Holdings, Inc. Common Stock (CERO)$358150N/AN/A0.0%68.9%0.0%0.00%
    Onconetix Inc (ONCO)$2.15MN/A1.0x0.0%N/A-83.9%0.00%
    Matinas BioPharma Holdings Inc (MTNB)$8815700.9xN/A0.0%-187.9%-100.0%0.00%
    Scisparc Ltd (SPRC)$869840N/AN/A0.0%N/A-38.4%0.00%
    Scinai Immunotherapeutics Ltd (SCNI)$1.05MN/AN/A-80.1%N/A572.0%0.00%
    HCW Biologics Inc (HCWB)$1.73MN/A0.2x-83.1%-51.6%1970.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    GeoVax Labs Inc (GOVX)$928290N/AN/A0.0%N/A-100.0%0.00%
    Virax Biolabs Group Limited Ordinary Shares (VRAX)$823940N/A14.3x0.0%N/A685.0%0.00%
    Oragenics Inc (OGEN)$906900N/AN/A0.0%-656.1%-91.3%0.00%
    Silexion Therapeutics Corp (SLXN)$1.29MN/A5.9x0.0%N/A0.0%0.00%
    Peer median$9175950.9x3.5x0.0%-51.6%-6.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to CDT Equity, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Karyopharm Therapeutics Inc (KPTI)
    Karyopharm Therapeutics Inc., a pharmaceutical company, is dedicated to the discovery...
    KPTI competitors
    CERo Therapeutics Holdings, Inc. Common Stock (CERO)
    CERo Therapeutics Holdings, Inc. is a biopharmaceutical company dedicated to advancing innovative therapies for patients with serious diseases.
    Onconetix Inc (ONCO)
    Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions.
    ONCO competitors
    Matinas BioPharma Holdings Inc (MTNB)
    Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of several candidate products.
    MTNB competitors
    Scisparc Ltd (SPRC)
    SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules.
    Scinai Immunotherapeutics Ltd (SCNI)
    Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune...
    SCNI competitors
    HCW Biologics Inc (HCWB)
    HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues...
    HCWB competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    GeoVax Labs Inc (GOVX)
    GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified...
    GOVX competitors
    Virax Biolabs Group Limited Ordinary Shares (VRAX)
    Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE...
    Oragenics Inc (OGEN)
    Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida.
    OGEN competitors
    Silexion Therapeutics Corp (SLXN)
    Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine...
    SLXN competitors

    Frequently Asked Questions About CDT

    Who are CDT Equity's main competitors?

    The companies most similar to CDT Equity include Karyopharm Therapeutics (KPTI), CERo Therapeutics Holdings, Inc. Common Stock (CERO), Onconetix (ONCO), Matinas BioPharma Holdings (MTNB) and Scisparc (SPRC), listed from the closest match.

    Who is CDT Equity's biggest competitor?

    Onconetix (ONCO) is the largest of the similar companies at $2.15M; Karyopharm Therapeutics (KPTI) is the closest match by business profile, size, sector and industry.

    How does CDT stock compare with its competitors?

    CDT's net margin is 0.0% against a peer median of 0.0%.

    Which of CDT Equity's competitors pays a higher dividend?

    CDT Equity pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is CDT Equity bigger than its competitors?

    No. CDT Equity is 11th by market cap among the 13 companies on this page; the largest is Onconetix (ONCO) at $2.15M.